Cited by 189Opioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesHIV, Drug Use, Sexual Risk

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

Touchpoints—opportunities to predict and prevent opioid overdose: a cohort study.

Open access

Larochelle, Marc R., Bernstein, Ryan, Bernson, Dana, Land, Thomas, Stopka, Thomas J., Rose, Adam J., Bharel, Monica, Liebschutz, Jane M., Walley, Alexander Y.·2019·Drug and Alcohol Dependence

DOI 10.1016/j.drugalcdep.2019.06.039PMC PMC7020606

Open this paper in CoChat — free account

Abstract

Background Medical care, public health, and criminal justice systems encounters could serve as touchpoints to identify and intervene with individuals at high-risk of opioid overdose death. The relative risk of opioid overdose death and proportion of deaths that could be averted at such touchpoints are unknown.Methods We used 8 individually linked data sets from Massachusetts government agencies to perform a retrospective cohort study of Massachusetts residents ages 11 and older. For each month in 2014, we identified past 12-month exposure to 4 opioid prescription touchpoints (high dosage, benzodiazepine co-prescribing, multiple prescribers, or multiple pharmacies) and 4 critical encounter touchpoints (opioid detoxification, nonfatal opioid overdose, injection-related infection, and release from incarceration). The outcome was opioid overdose death. We calculated Standardized Mortality Ratios (SMRs) and Population Attributable Fractions (PAFs) associated with touchpoint exposure.Results The cohort consisted of 6,717,390 person-years of follow-up with 1315 opioid overdose deaths. We identified past 12-month exposure to any touchpoint in 2.7% of person-months and for 51.8% of opioid overdose deaths. Opioid overdose SMRs were 12.6 (95% CI: 11.1, 14.1) for opioid prescription and 68.4 (95% CI: 62.4, 74.5) for critical encounter touchpoints. Fatal opioid overdose PAFs were 0.19 (95% CI: 0.17, 0.21) for opioid prescription and 0.37 (95% CI: 0.34, 0.39) for critical encounter touchpoints.Conclusions Using public health data, we found eight candidate touchpoints were associated with increased risk of fatal opioid overdose, and collectively identified more than half of opioid overdose decedents. These touchpoints are potential targets for development of overdose prevention interventions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.drugalcdep.2019.06.039

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161 · cited 9×
“An evaluation of one program demonstrated feasibility in initiating MOUD with successful linkage to post-discharge care, and a pragmatic multi-site trial of inpatient addiction consult services is underway (McNeely et al., 2019; Trowbridge et al., 2017).”
BackgroundInfluential
Increases in drug and opioid-involved overdose deaths – United States, 2010-2015
Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm655051e1 · Cited by 2,194 · cited 1×
“(Rudd et al., 2016) Several overdose risk factors are well-established and can be identified through medical care, public health, or criminal justice systems encounters.”
Background
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.
Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017) · BMJ · doi:10.1136/bmj.j1550 · Cited by 1,816 · cited 1×
“Naloxone distribution programs and treatment with medications for opioid use disorder (MOUD) are associated with reduced opioid overdose mortality (McDonald and Strang, 2016; Sordo et al., 2017; Walley et al., 2013).”
Background
Release from prison–a high risk of death for former inmates
Binswanger, I. A., Stern, M. F., Deyo, R. A., Heagerty, P. J., Cheadle, A., Elmore, J. G., & Koepsell, T. D. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa064115 · Cited by 1,684
Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths
Bohnert, A. S. B. (2011) · JAMA · doi:10.1001/jama.2011.370 · Cited by 1,509 · cited 1×
“Known opioid prescription touchpoints associated with increased risk of fatal opioid overdose include high opioid dosage, co-prescribing opioids and benzodiazepines, and receiving or filling opioid prescriptions from multiple providers or pharmacies (Baumblatt et al., 2014; Bohnert et al., 2011; Dunn et al., 2010; Gar…”
Background
Opioid Prescriptions for Chronic Pain and Overdose
Dunn, K. M., Saunders, K. W., Rutter, C. M., Banta‐Green, C. J., Merrill, J. O., Sullivan, M. D., Weisner, C. M., Silverberg, M. J., Campbell, C. I., Psaty, B. M., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00006 · Cited by 1,265 · cited 1×
“Known opioid prescription touchpoints associated with increased risk of fatal opioid overdose include high opioid dosage, co-prescribing opioids and benzodiazepines, and receiving or filling opioid prescriptions from multiple providers or pharmacies (Baumblatt et al., 2014; Bohnert et al., 2011; Dunn et al., 2010; Gar…”
Background
Vital signs: changes in opioid prescribing in the United States, 2006-2015.
Guy, G. P., Zhang, K., Bohm, M. K., Losby, J., Lewis, B., Young, R., Murphy, L. B., & Dowell, D. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6626a4 · Cited by 1,117
Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study
Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., Bagley, S. M., Liebschutz, J. M., & Walley, A. Y. (2018) · Annals of Internal Medicine · doi:10.7326/m17-3107 · Cited by 1,076 · cited 3×
“More specifically, studies among overdose survivors and individuals released from incarceration have shown MOUD are associated with reduced opioid overdose death yet a minority receive them (Green et al., 2018; Larochelle et al., 2018).”
BackgroundMethodSelf-citation
Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis
Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013) · BMJ · doi:10.1136/bmj.f174 · Cited by 999 · cited 1×
“Naloxone distribution programs and treatment with medications for opioid use disorder (MOUD) are associated with reduced opioid overdose mortality (McDonald and Strang, 2016; Sordo et al., 2017; Walley et al., 2013).”
Background
Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence
D’Onofrio, G., O’Connor, P. G., Pantalon, M. V., Chawarski, M. C., Busch, S. H., Owens, P. H., Bernstein, S. L., & Fiellin, D. A. (2015) · JAMA · doi:10.1001/jama.2015.3474 · Cited by 913

Show all 52 references

Sorted by citations

Items 101–189 of 189

Healthcare utilization trends among patients with opioid use disorder in U.S. Hospitals: an analysis of length of stay, total charges, and costs, 2005–2020
Qeadan, F., Nicolson, A., Tingey, B., Moffett, M. L., & Azagba, S. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-13095-9 · Cited by 8
Onsite buprenorphine inductions at harm reduction agencies to increase treatment engagement and reduce HIV risk: Design and rationale
Perez-Correa, A., Abbas, B. T., Riback, L. R., Ghiroli, M. M., Norton, B. L., Murphy, S. M., Jakubowski, A. U., Hayes, B. T., Cunningham, C. O., & Fox, A. D. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106674 · Cited by 8
Civil commitment for opioid misuse: do short-term benefits outweigh long-term harms?
Messinger, J. C., Ikeda, D. J., & Sarpatwari, A. (2021) · Journal of Medical Ethics · doi:10.1136/medethics-2020-107160 · Cited by 8
Utilising an access to care integrated framework to explore the perceptions of hepatitis C treatment of hospital-based interventions among people who use drugs
Levander, X. A., Vega, T. A., Seaman, A., Korthuis, P. T., & Englander, H. L. (2021) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103356 · Cited by 8
Racial equity in linkage to inpatient opioid use disorder treatment in patients that received emergency care
Faiz, J., Bernstein, E., Dugas, J. N., Schechter‐Perkins, E. M., Nentwich, L. M., Nelson, K. P., Manchanda, E. C. C., Young, L., & Pare, J. R. (2022) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2022.01.037 · Cited by 8
Implementation of a post-overdose quick response team in the rural Midwest: A team case study
Canada, M., & Formica, S. W. (2022) · Journal of Community Safety and Well-Being · doi:10.35502/jcswb.233 · Cited by 8
“Individuals who survive a drug-related overdose are at higher risk for future drug overdose (Darke et al., 2011; Larochelle et al., 2019).”
Background
Post-overdose follow-up in the community with peer recovery specialists: The Lake Superior Diversion and Substance Use Response Team
Ray, B. R., McCarthy-Nickila, J., Richardson, N. J., & Maahs, J. R. (2023) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2023.100139 · Cited by 8
Saving Lives: The Veterans Health Administration (VHA) Rapid Naloxone Initiative
Oliva, E. M., Richardson, J., Harvey, M., & Bellino, P. (2021) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2021.06.004 · Cited by 8
Using Data-To-Care Strategies to Optimize the HIV Care Continuum in Connecticut: Results From a Randomized Controlled Trial
Machavariani, E., Miceli, J., Altice, F. L., Fanfair, R. N., Speers, S., Nichols, L., Jenkins, H., & Villanueva, M. S. (2024) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003391 · Cited by 7
“…for re-engagement at other touchpoints (eg, emergency departments, hospitals, drug treatment programs, and community-based organizations) 43 where laboratory assessments were obtained to meet the retention in care de ﬁ nition, but for which patients were not fully engaged in their HIV…”
Background
Comparing Practices Used in Overdose Fatality Review Teams to Recommended Implementation Guidelines
Ray, B. R., Bailey, K., Dunnigan, M., Aalsma, M. C., Bell, L. A., & O’Brien, M. (2022) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000001546 · Cited by 7
“Assessing the combined information from a variety of sources holds great potential for identifying overdose prevention touchpoints.(25) Research on the overdose fatality case review process and its outcomes remains limited, but some studies suggest that the process can improve coordination between service providers, s…”
Background
The cascade of care for commercially-insured persons with opioid use disorder and comorbid HIV and HCV infections
Ivasiy, R., Madden, L. M., DiDomizio, E. E., Johnson, K., Machavariani, E., Ahmad, B., Oliveros, D., Ram, A. V., Kil, N., & Altice, F. L. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.112410 · Cited by 7
The Role of Health Plans in Addressing the Opioid Crisis: A Qualitative Study
Davis, M. T., Bohler, R. M., Hodgkin, D., Hamilton, G. A., & Horgan, C. M. (2022) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2023.209022 · Cited by 7
Development of a Real-Time Dashboard for Overdose Touchpoints: User-Centered Design Approach
Salvi, A., Gillenwater, L. A., Cockrum, B., Wiehe, S. E., Christian, K., Cayton, J., Bailey, T., Schwartz, K., Dir, A. L., Ray, B. R., et al. (2024) · JMIR Human Factors · doi:10.2196/57239 · Cited by 6
“When brought to light, touchpoints offer key opportunities to engage at-risk individuals and connect them with prevention services and treatments [25-27].”
Background
The Mobile Overdose Response Program: A mobile, low-threshold opioid use disorder treatment model in Philadelphia
Lowenstein, M., Popova, E., Jalloh, A., Mazzella, S., Botcheos, D., Bertocchi, J., Westfahl, S., Garcia, K. P., Truchil, R., & Chertok, J. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209429 · Cited by 6
Implementing and documenting cultural adaption of evidence-based practice strategies to reduce opioid overdose deaths: examples and lessons from the HEALing communities study
Gibson, E. B., Glasgow, L., Nouvong, M., McGladrey, M., Freedman, D. A., Chassler, D., Vickers‐Smith, R., D’Onfro, M., Goddard‐Eckrich, D., Hunt, T., et al. (2025) · Discover Public Health · doi:10.1186/s12982-025-00696-2 · Cited by 6
“…opioid overdose [11], 2) have a reduced ability to tolerate opioids (e.g., those who have not used opioids for a while after release from jails, treatment centers, and hospitals) [12], 3) use other drugs [13], 4) have serious mental health problems [14], and/or 5) major medical conditions [15].”
Health care and harm reduction provider perspectives on treating older adults who use non-medical opioids: a qualitative study set in Chicago
Mason, M., Post, L. A., & Aggarwal, R. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-09843-4 · Cited by 6
“Health care and harm reduction encounters can play a key role in prevention of OOD, providing key touchpoints for screening, treatment initiation, and harm reduction outreach [12].”
Background
Imprisonment, community sanctions and mortality by cause of death among patients with substance use disorder – a 28-year follow-up using Finnish register data
Laine, R., Myrskylä, M., Kaskela, T., & Pitkänen, T. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109327 · Cited by 5
Prevalence and associates of non-fatal overdose among people who inject drugs in Saveh, Iran
Armoon, B., Griffiths, M. D., Bayani, A., Mohammadi, R., & Ahounbar, E. (2022) · Addiction Science & Clinical Practice · doi:10.1186/s13722-022-00325-2 · Cited by 5
“Better knowledge and use of these services are likely to reduce the likelihood of overdose among PWID [9, 40, 41].”
Background
Methadone Induction for a Patient With Precipitated Withdrawal in the Emergency Department: A Case Report
Church, B. J., Clark, R., Mohn, W., Potee, R. A., Friedmann, P. D., & Soares, W. E. (2022) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001109 · Cited by 5
Opioid prescriber screening practices to detect risk for developing opioid use disorder: Qualitative perspectives from providers during the fourth wave of the opioid crisis
Skeer, M., Yang, J.-E., Booth, M., Robison, E., Hajinazarian, G., Boyadjian, T., Sabelli, R. A., Chui, K., & Stopka, T. (2023) · SSM - Qualitative Research in Health · doi:10.1016/j.ssmqr.2023.100281 · Cited by 3
Aligning public health and public safety: Probation as a touchpoint to identify and link patients with opioid use disorder to opioid agonist treatment
Bromberg, D. J., de Leon, S. J. G., Litz, T., Azbel, L., Liberman, A. R., Polonsky, M., Дворяк, С., Saichuk, N., Taxman, F. S., & Altice, F. L. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0002349 · Cited by 5
Health and Economic Outcomes of Offering Buprenorphine in Homeless Shelters in Massachusetts
Chatterjee, A., Stewart, E. A., Assoumou, S. A., Chrysanthopoulou, S. A., Zwick, H. C., Harris, R. A., O’Dea, R., Schackman, B. R., White, L. F., & Linas, B. P. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.37233 · Cited by 5
Expanding Inpatient Addiction Consult Services Through Accountable Care Organizations for Medicaid Enrollees: A Modeling Study
King, C. A., Cook, R., Korthuis, P. T., McCarty, D., Morris, C. D., & Englander, H. (2022) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000972 · Cited by 5
“Hospitalization is a touchpoint to engage patients with OUD, initiate evidence-based treatment, and link patients to community treatment programs, including Opioid Treatment Programs (OTPs) and X-waivered buprenorphine providers.(3) Initiating medication for OUD (MOUD) in the hospital can reduce post-discharge mortali…”
Background
Impact of Substance Use Navigators on Initiation of Treatment for Substance Use Disorders and 30-Day Unplanned Readmission
Campbell, A., Rosen, A. D., SHOPTAW, S. J., Herring, A. A., Jay, D., Moulin, A. K., LaMers, J., Samuels, E. A., & Gietzen, L. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09902-y · Cited by 4
Geographic and Racial/Ethnic Differences in Access to Methamphetamine Detoxification Services, United States, 2021
Pro, G. C., Cantor, J., Buttram, M. E., Brown, C. C., Gu, M., Mancino, M. J., & Zaller, N. D. (2024) · Medical Care · doi:10.1097/mlr.0000000000002013 · Cited by 4
“30 Harm reduction services are another key catalyst for promoting treatment-seeking behavior 31 and are undoubtedly well-positioned to advocate for and assist with detox and subsequent treat-ment admission.”
Background
The changing role of substances: trends, characteristics of individuals and prior healthcare utilization among individuals with accidental substance-related toxicity deaths in Ontario Canada
Ledlie, S., Holton, A. E., Leece, P., Hamzat, B., Yang, J. C., Kolla, G., Bozinoff, N., Boyd, R., Franklyn, M., Smoke, A., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324732 · Cited by 4
“…increasingly represent important opportunities to provide care to people who use substances, including treatment initiation for those with a substance use disorder diagnosis and coordination of connections with harm reduction, substance use treatment and primary care services upon discharge [50].”
Building connection: overdose survivors’ and professional service providers’ perspectives on immediate post-overdose care
Paradise, R. K., Kimmel, S. D., Nurani, A., Desmarais, J., O’Malley, S., Walley, A. Y., Hoyos-Céspedes, A., Clarke, J., Taylor, S., Dooley, D. P., et al. (2025) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2025.104948 · Cited by 4
“…a risk factor for future fatal overdose and often results in activation of emergency medical services (EMS), representing an important opportunity for connecting survivors to treatment and other services (Caudarella et al., 2016; Darke et al., 2011; Krawczyk et al., 2020; Larochelle et al., 2019).”
Use of Big Data and Ethical Issues for Populations With Substance Use Disorder
Evans, E., & Geissler, K. H. (2023) · Value in Health · doi:10.1016/j.jval.2023.02.019 · Cited by 4
Precipitated Withdrawal, Delirium, and Cerebellar Stroke: The Pharmacology of Buprenorphine Induction in Non-pharmaceutical Fentanyl and the Neuropsychiatric Manifestations of Cerebellar Stroke
Montalvo, C., von Horn, A., Lane, C. E., Weinstein, Z., Sharma, M., & Suzuki, J. (2021) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000305 · Cited by 4
Against Our Instincts: Decriminalization of Buprenorphine
Messinger, J. C., Chukka, A., & Boyd, J. W. (2022) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2022.02.210308 · Cited by 4
Efficacy of Low-Dose Versus Traditional Buprenorphine Induction in the Hospital: A Quantitative and Qualitative Study
Sulakvelidze, N., Ronan, C., Peterkin, A. F., & Weinstein, Z. (2022) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001573 · Cited by 4
Concordance between controlled substance receipt and post-mortem toxicology in opioid-detected overdose deaths: A statewide analysis
Howell, B. A., Black, A. C., Grau, L. E., Lin, H., Greene, C., Lee, H., Heimer, R., Hawk, K. F., D’Onofrio, G., Fiellin, D. A., et al. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109788 · Cited by 4
Receptivity to Jail-based medication for opioid use disorder among rural detention Administrators
Thomas, S. D., Singer, A. J., & Kopak, A. M. (2023) · Corrections · doi:10.1080/23774657.2023.2278195 · Cited by 5
“Evidence has shown that those who have recently been incarcerated are 30 to 40 times as likely to succumb to fatal opioid overdose compared to the general population (Larochelle et al., 2019; Merrall et al., 2010; Ranapurwala et al., 2018).”
Characterising individuals with a substance use disorder accessing hospital‐based addiction care: Preliminary description of the outcomes for patients accessing addiction care prospective cohort study
James, H., Morgan, J., & Nolan, S. (2024) · Drug and Alcohol Review · doi:10.1111/dar.13888 · Cited by 3
One-Year Mortality Among Opioid Overdose Survivors
Kleinman, R. A., Larney, S., Sule, N. O., Ma, C., Hauck, T. S., & Kurdyak, P. (2026) · JAMA · doi:10.1001/jama.2026.6469 · Cited by 3
Cross sectional analysis of an addiction consultation service, substance co-use patterns, and receipt of medications for opioid use disorder during hospitalization
Shearer, R. D., Bart, G. B., Beebe, T. J., Virnig, B. A., Shippee, N. D., & Winkelman, T. N. A. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209505 · Cited by 3
Court Navigators and Opportunities for Disseminating Overdose Prevention Strategies
Ray, B. R., Jensen, S., Desjardins, M. M., Haggerty, J., & Larson, M. (2024) · Health Promotion Practice · doi:10.1177/15248399241275623 · Cited by 3
“…in large part from the criminalization of substances at federal and state levels, which is enforced through resources allocated specifically toward policing drug possession and distribution and perpetuates the carceral churn (Del Pozo et al., 2021; Larochelle et al., 2019; Shefner et al., 2020).”
Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trial
Brown, J. L., Larochelle, M. R., Fanucchi, L. C., Calvert, D., Campbell, A. N. C., Chandler, R. K., Feaster, D. J., Glasgow, L., Gibson, E. B., Holloway, J., et al. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112785 · Cited by 3
Exploring how Hospitalization Can Alter Hepatitis C Virus Treatment Prioritization and Trajectories in People who Use Drugs: A Qualitative Analysis
Levander, X. A., Vega, T. A., Seaman, A., Korthuis, P. T., & Englander, H. L. (2021) · Substance Abuse · doi:10.1080/08897077.2021.1932699 · Cited by 3
Advancing Best Practices for Hospitalized Patients with a Volunteer Addiction Consult Team
Goodman, C. W., Rhodes, M. A., Thompson, B. W., Brazell, B., & Litwin, A. H. (2021) · The American Journal of Medicine · doi:10.1016/j.amjmed.2021.07.047 · Cited by 3
Receipt of addiction treatment after nonfatal opioid overdose and risk of subsequent overdose: A retrospective cohort study
Howell, B. A., Black, A. C., Lin, H., Liberatore, M. A., Greene, C. R., D’Onofrio, G., Heimer, R., Grau, L. E., Hawk, K. F., Fiellin, D. A., et al. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112679 · Cited by 2
Leveraging the 72-Hour Rule Change to Support Transition From Hospital to Opioid Treatment Program
Calcaterra, S. L., Weimer, M. B., Grimm, E., Scherbak, Y., Galil, R. A., Berger, O., Bowman, L. A., Nesbit, S. A., Barany, A., & Buresh, M. E. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.44996 · Cited by 2
"So what's gonna happen when I get out of here?" Qualitative barriers and facilitators to MOUD continuity post-release from jail
Stopka, T. J., Rottapel, R. E., Ruggiro, M., Santelices, C., Friedmann, P. D., Pivovarova, E., & Evans, E. (2026) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2026.113227 · Cited by 2
Real-Time Dashboard for Identifying Overdose Touchpoints in Indiana
Ray, B. R., Huntsinger, D., Christian, K., Gillenwater, L. A., Rinderle, A., Dir, A. L., Aalsma, M. C., & Reda, K. (2024) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000002000 · Cited by 2
Bridging the gap: An environmental scan of post-overdose program features and evaluation measures
Ferg, M., Rapisarda, S. S., Soranno, E., Lewis, N. M., Ottoson, A., & Tschampl, C. A. (2024) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2024.104651 · Cited by 2
Recovery Capital and Subsequent Overdose Risk and Addiction Treatment Engagement Among Emergency Department Patients at High Risk of Opioid Overdose
Chambers, L. C., Welwean, R., Cho, D. K., Langdon, K. J., Li, Y., Hallowell, B. D., Daly, M. M., Marshall, B. D. L., & Beaudoin, F. L. (2024) · Substance Use & Misuse · doi:10.1080/10826084.2024.2434003 · Cited by 2
“These eligibility criteria were based on previously established risk factors for overdose (Kline et al., 2023; Larochelle et al., 2019; Pavarin et al., 2016; Saloner et al., 2020; Wang et al., 2023).”
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versus treatment as usual on post-hospital treatment engagement for hospitalized patients with opioid use disorder
Bart, G. B., Barth, K. S., Baukol, P., Enns, E. A., Ghitza, U. E., Harris, J., Jelstrom, E., Liebschutz, J. M., Magane, K. M., Voronca, D., et al. (2024) · Addiction Science & Clinical Practice · doi:10.1186/s13722-024-00510-5 · Cited by 2
Addressing data gaps in opioid overdose reporting: enhancing systems to protect vulnerable older adults
Alonzo, J. P., Romain-Harrott, M., Campbell, W., Clancy, K., Biggers, K., & Ory, M. G. (2025) · Innovation in Aging · doi:10.1093/geroni/igaf070 · Cited by 3
Implementing Harm Reduction Strategies to Reduce Opioid Overdoses
Brown, N. (2021) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2021.02.030 · Cited by 2
Using RE-AIM Framework to Evaluate Recovery Opioid Overdose Team Plus: A Peer-Led Post-overdose Quick Response Team
Dahlem, C. H., Dwan, M., Dobbs, B., Rich, R., Jaffe, K., & Shuman, C. J. (2024) · Community Mental Health Journal · doi:10.1007/s10597-024-01319-x · Cited by 2
“…soon after an overdose is one “touchpoint” to engage with the survivor and our predominant reasons for lack of engagement were related to communication barriers in this study, consistent with previous research (Anvari et al., 2021; King et al., 2023; Larochelle et al., 2019; Simpson et al., 2022).”
Low-Dose Buprenorphine Initiation for Hospitalized Patients With Chronic Pain and Opioid Use Disorder or Opioid Misuse: Protocol for an Open-Label, Parallel-Group, Effectiveness-Implementation Randomized Controlled Trial
Hayes, B. T., Sanchez-Fat, G., Torres‐Lockhart, K., Khalid, L., Minami, H., Ghiroli, M. M., Hribar, M., Pacífico, J., Bao, Y., Rodgers, C. R. R., et al. (2024) · Substance Use & Addiction Journal · doi:10.1177/29767342241263221 · Cited by 1
“32-34 Initiating buprenorphine treat-ment during hospitalization improves linkage to outpatient OUD treatment.”
Predicting fatal opioid-involved overdoses: A social-ecological framework matched to a linked-data warehouse
Bayly, R., Cordes, J., Bernson, D., Ackerson, L. K., Larochelle, M. R., Hassan, G. H., Bauer, C., & Stopka, T. J. (2025) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2025.104730 · Cited by 1
Post-overdose outreach programs in Massachusetts before and after the onset of the COVID-19 pandemic
Walley, A. Y., Wang, J., To, C., Duska, M., Murray, S., Wiggins, M., Rolles, A., Yan, S., Kosakowski, S., Bagley, S. M., et al. (2025) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2025.209799 · Cited by 1
Potential health impacts of comprehensive access to opioid use disorder treatment in United States correctional facilities: A synthetic analysis
Smith, J. J., Noonan, M. E., Johnson, C. E., Humphreys, K. N., & Gupta, R. (2025) · Addiction · doi:10.1111/add.70170 · Cited by 1
Willingness to receive medication for opioid use disorder (MOUD): A longitudinal analysis of social network support
Knudsen, H. K., Rockett, M., & Oser, C. B. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112966 · Cited by 1
History of Naloxone Possession Among Rural and Urban Individuals Participating in Prison-Based Treatment: An Observational Study
Knudsen, H. K., Batty, E. J., Staton, M., Traxler, H. K., & Oser, C. B. (2026) · Substance Use & Addiction Journal · doi:10.1177/29767342251401705 · Cited by 1
Biosurveillance and the Opioid Crisis in Emergency Medicine: Qualitative Study of Physician Perspectives
Stilley, J. A. W., Benton, M., Douglas, A. E., & Kapp, J. M. (2026) · JMIR Formative Research · doi:10.2196/82865 · Cited by 1
“EDs are critical touchpoints for providing persons who use drugs with overdose prevention resources and linkages to care, as those who experience a nonfatal opioid overdose are at increased risk of a subsequent overdose [11].”
Antithrombotic Usage, Including Three-Year Outcomes With Dabigatran and Vitamin K Antagonists for Atrial Fibrillation, in Eastern Europe: A Descriptive Analysis From Phase 3 of the GLORIA-AF Registry
Bergler-Klein, J. K., Gotcheva, N. N., Kalējs, O., Kalarus, Z. F., Kovačić, D., Peršić, V., Shlyakhto, E. V., Uuetoa, T., Huisman, M. V., Lip, G. Y. H., et al. (2023) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001655
Implementation and evaluation of interprofessional overdose review team recommendations following intentional or accidental overdose events
Barrett, M., Kemerer, S., & Colvard, M. D. (2024) · Mental Health Clinician · doi:10.9740/mhc.2024.06.224
The Optimal Design of Service Contact Point of Convenience Store Based on TRIZ Theory
饶, 耀. (2024) · Modern Management · doi:10.12677/mm.2024.149287
Integrating Mental Health and Substance Use Treatment With Emergency and Primary Care: the Case of Opioid Use Disorder and Suicide
Krawczyk, N., & Samples, H. (2025) · Milbank Quarterly · doi:10.1111/1468-0009.70028
Reducing Prescription Opioid Dose and Duration to Reduce Risk of Opioid Use Disorder Among Patients With Musculoskeletal Pain
Inose, S., Williams, N., Hoffman, K. L., Perry, A., Diaz, I. M., & Rudolph, K. E. (2025) · Epidemiology · doi:10.1097/ede.0000000000001899
Understanding the Opioid Overdose Crisis: A Comprehensive Bibliometric Analysis
Altherwi, T. I. (2025) · International Journal of Pharmacology · doi:10.31083/ijp44192
A qualitative study exploring motivations for participating in research among women who use opioids
Bagley, S. M., Maschke, A., Harris, M. T. H., Walley, A. Y., Johnson, S., Hurstak, E., Farley, J., Keller, S. G., McMahan, V., Barrett, C. T., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0336061
Additional file 1 of Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study
Stopka, T. J., Rottapel, R. E., Friedmann, P. D., Pivovarova, E., & Evans, E. (2024) · Figshare · doi:10.6084/m9.figshare.27012310
Additional file 3 of A scoping review of factors that influence opioid overdose prevention for justice-involved populations
Grella, C. E., Ostlie, E. M., Scott, C. K., Dennis, M. L., Carnevale, J. T., & Watson, D. P. (2021) · Figshare · doi:10.6084/m9.figshare.14091442
Additional file 1 of Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorder
Bart, G., Korthuis, P. T., Donohue, J. M., Hagedorn, H., Gustafson, D., Bazzi, A., Enns, E. A., McNeely, J., Ghitza, U. E., Magane, K. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25583937
Additional file 2 of A scoping review of factors that influence opioid overdose prevention for justice-involved populations
Grella, C. E., Ostlie, E. M., Scott, C. K., Dennis, M. L., Carnevale, J. T., & Watson, D. P. (2021) · Figshare · doi:10.6084/m9.figshare.14091439
Additional file 2 of Record linkage studies of drug-related deaths among adults who were released from prison to the community: a scoping review
Cooper, J. A., ONYEKA, I., Cardwell, C., Paterson, E., Kirk, R., O’Reilly, D., & Donnelly, M. (2024) · Figshare · doi:10.6084/m9.figshare.26587194
Additional file 1 of Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology
Krawczyk, N., Rivera, B. D., Chang, J. E., Grivel, M. M., Chen, Y.-H., Nagappala, S., Englander, H. L., & McNeely, J. (2024) · Figshare · doi:10.6084/m9.figshare.26634816
Additional file 1 of Record linkage studies of drug-related deaths among adults who were released from prison to the community: a scoping review
Cooper, J. A., Onyeka, I., Cardwell, C., Paterson, E., Kirk, R., O’Reilly, D., & Donnelly, M. (2024) · Figshare · doi:10.6084/m9.figshare.26587191
Additional file 2 of Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorder
Bart, G., Korthuis, P. T., Donohue, J. M., Hagedorn, H., Gustafson, D., Bazzi, A., Enns, E. A., McNeely, J., Ghitza, U. E., Magane, K. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25584061
Additional file 1 of Older adult drug overdose: an application of latent class analysis to identify prevention opportunities
Mason, M., Pandya, K., & Lundberg, A. (2024) · Figshare · doi:10.6084/m9.figshare.25405981
Additional file 1 of A scoping review of factors that influence opioid overdose prevention for justice-involved populations
Grella, C. E., Ostlie, E. M., Scott, C. K., Dennis, M. L., Carnevale, J. T., & Watson, D. P. (2021) · Figshare · doi:10.6084/m9.figshare.14091436
Real-Time Expert Support for Addiction Care Across General Medical Settings: Evaluation of a Chat-Based Intervention
Ochoa, K. N., Vincent, A. C., Christensen, S., Christine, P. J., & Pytell, J. D. (2026) · Substance Use & Addiction Journal · doi:10.1177/29767342251404228
Opioid Use Disorder Care Presentations After High-deductible Health Plan Enrollment
Shuey, B., Zhang, F., Argetsinger, S., Costa, R., Wen, H., & Wharam, J. F. (2026) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001662
Perspectives on Clinical Champions Implementing Hospital-Based Opioid Treatment in US Hospitals
Peng, L., Goff, A., Patten, A., Bazzi, A. R., King, C., Siegler, T., Weinstein, Z., Shearer, R. D., Hagedorn, H., Oot, E. N., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.0446
Implementation of addiction consult services and bridge clinics in the HEALing communities study in Massachusetts
Weinstein, Z., Jadovich, E., Drainoni, M., Larochelle, M. R., Yan, S., Lee, J. W., Bettano, A. L., Beers, D., Walley, A. Y., & Samet, J. H. (2026) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2026.113165
A comparison of opioid overdose risk behaviors by race and ethnicity among overdose survivors in Boston, MA, and San Francisco, CA
Reed, G. E., McMahan, V., Chang, Y.-S. G., Johnson, N. L., Walley, A. Y., Coffin, P. O., & Harris, M. T. H. (2026) · Harm Reduction Journal · doi:10.1186/s12954-026-01451-9
Mandated Drug Treatment in the Criminal Legal System—a Blunt but Necessary Tool?
Saloner, B. K. (2026) · The Hastings Center Report · doi:10.1002/hast.70038
Community coalition’s diversity and targeted overdose prevention strategies designed to reach special populations
Goddard‐Eckrich, D., Chahine, R. A., Glasgow, L., Oga, E. A., Miles, J., Holloway, J., Hall, M. E., Bagley, S. M., Kim, E., Davis, A., et al. (2026) · Harm Reduction Journal · doi:10.1186/s12954-026-01458-2
Probation as a targeted entry point for scaling up opioid agonist therapies in Moldova using a modified screening, brief intervention and referral to treatment strategy
Ponticiello, M. N., Bromberg, D. J., Azbel, L., Cugut, S., Doltu, S., & Altice, F. L. (2026) · PLOS Global Public Health · doi:10.1371/journal.pgph.0006317
ASAM Consensus Standards for Substance Use Disorder Care Capabilities in Hospitals and Emergency Departments
Wakeman, S., Bachireddy, C., Campbell, A., Danovitch, I., Englander, H., Fuller, D., Herring, A., McCollough, M., Lindsay, D. L., Norrington, J., et al. (2026) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001729
County-Based Extension Agents' Perspectives on the Implementation of MedSMA℞T Families for Opioid Safety Education in Kentucky (Preprint)Preprint
Oladapo, R. K., Strong, J., Adedokun, O. A., Song, Y., Elswick, A., Gangnon, R. E., & Abraham, O. (2026) · doi:10.2196/preprints.105475
Preparing Emergency Medical Services for Prehospital Buprenorphine: Examining a Train-the-Trainer Approach to Strengthening the Overdose Chain of Survival
Paschke, M., Siddiqui, S. T., Wilson, J., Carroll, G. G., Kroll, M., Ray, B. R., & Winograd, R. (2026) · Journal of the American College of Emergency Physicians Open · doi:10.1016/j.acepjo.2026.100452
Barriers to Population Data Use in Overdose Fatality Reviews: Observational and Interview Study of Dashboard Deployment
Salvi, A., Holladay, C., Dir, A. L., Ray, B. R., Aalsma, M. C., & Reda, K. (2026) · JMIR Human Factors · doi:10.2196/98864
“To address this opportunity, we partnered with the Indiana state government starting in September 2022 to develop and deploy a dashboard that provides OFR teams with real-time data about touchpoints—events and services individuals interact with before experiencing a fatal overdose [9,10].”
Transdermal Buprenorphine in Low-Dose Induction Strategies for Opioid Use Disorder: A Case Report and Systematic Review
Pothikamjorn, A., Suen, W.-L., Hill, K. P., & Sarkar, P. R. (2026) · Journal of the Academy of Consultation-Liaison Psychiatry · doi:10.1016/j.jaclp.2026.09.001
Usability and Perceived Acceptability of the MedSMA℞T: Adventures in PharmaCity Opioid Safety Serious Game Among County-Based Extension Agents in Kentucky: Single-Group Pretest-Posttest Formative Stakeholder Evaluation (Preprint)
Oladapo, R. K., Strong, J., Adedokun, O. A., Song, Y., Elswick, A., Gangnon, R. E., & Abraham, O. (2026) · JMIR Serious Games · doi:10.2196/105475
Initiatives to Prevent Fatal Drug Overdose Mortality After Incarceration
Brickner, S., Lopez, A. A., Boch, S. J., LeBel, T. P., & Polfuss, M. L. (2026) · Substance Use & Addiction Journal · doi:10.1177/29767342261492898

Authors: Larochelle, M. R., Bernstein, R., Bernson, D., Land, T., Stopka, T. J., Rose, A. J., Bharel, M., Liebschutz, J. M., & Walley, A. Y.
Affiliations: Boston University (US)
Massachusetts Department of Public Health (US)
University of Massachusetts Chan Medical School (US)
Tufts University (US)
RAND Corporation (US)
University of Pittsburgh (US)
Corresponding author: Larochelle, Marc R.
ORCID: Larochelle, Marc R.
Bernson, Dana
Stopka, Thomas J.
Rose, Adam J.
Liebschutz, Jane M.
Walley, Alexander Y.
Venue: Drug and Alcohol Dependence
Publisher: Elsevier BV
Published: 2019-11
Volume: 204
Pages: 107537
ISSN: 0376-8716 (ISSN-L)
DOI: 10.1016/j.drugalcdep.2019.06.039
PMC: PMC7020606
OpenAlex: W2971555090
Cited by: 189
References: 52
Citations by year: 2026: 20 · 2025: 21 · 2024: 36 · 2023: 25 · 2022: 23 · 2021: 47 · 2020: 16 · 2019: 1
FWCI: 20.03
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Drug and Alcohol Dependence (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: School of Medicine, Boston University
National Institute on Drug Abuse
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
Keywords: opioid overdose, overdose prevention, touchpoints, opioid prescribing, multiple prescribers, opioid detoxification, injection-related infections, incarceration, drug overdose deaths, population attributable fraction, standardized mortality ratio
MeSH terms: Adolescent, Adult, Analgesics, Opioid, Child, Criminal Law, Female, Forecasting, Humans, Male, Massachusetts, Middle Aged, Opioid-Related Disorders, Patient Acceptance of Health Care, Drug Prescriptions, Retrospective Studies, Risk, Young Adult, Drug Overdose

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Touchpoints—opportunities to predict and prevent opioid overdose: a cohort study.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks